A study of MenABCWY vaccine in healthy adolescents – to find out if it was safe and produced antibody responses against a germ called Neisseria meningitidis
A Phase 2b, Randomized, Observer-Blinded Trial to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on 2 Different Dosing Schedules in Healthy Participants ≥11 to <15 Years of Age
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06886992
ClinicalTrials.gov Identifier (NCT): NCT04440176
Protocol ID: C3511004
Open Plain Language Summary Result:
Click here